In a recent study published in the JAMA Network Open, a group of researchers evaluated the impact of exercise, glucagon-like peptide-1 receptor agonist (GLP-1 RA) liraglutide, and their combination on ...
Approximately one in eight Americans has taken a GLP-1 or glucagon-like peptide-1 receptor agonist. These medications were originally developed to help manage type 2 diabetes, but they also support ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback